Medmix AG (CHIX:MEDXZ) Long-Term Debt: CHF249.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDXZ Medmix AG CHIX:MEDXZ
66 GF Score
Price CHF8.54
GF Value CHF9.05
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medmix AG Long-Term Debt?

Medmix AG CHIX:MEDXZ +1.97% 66 Long-Term Debt is CHF249.6 Mil as of Jun. 2026. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review.

Medmix AG's Long-Term Debt for the quarter that ended in Jun. 2026 was CHF249.6 Mil.

Medmix AG's quarterly Long-Term Debt increased from Jun. 2025 (CHF248.7 Mil) to Dec. 2025 (CHF249.1 Mil) and increased from Dec. 2025 (CHF249.1 Mil) to Jun. 2026 (CHF249.6 Mil).

Medmix AG's annual Long-Term Debt increased from Dec. 2023 (CHF247.3 Mil) to Dec. 2024 (CHF248.2 Mil) and increased from Dec. 2024 (CHF248.2 Mil) to Dec. 2025 (CHF249.1 Mil).

Medmix AG  (CHIX:MEDXz) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medmix AG Long-Term Debt Related Terms

Medmix AG Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medmix AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG Long-Term Debt Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 238.90 246.90 247.30 248.20 249.10

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 247.70 248.20 248.70 249.10 249.60
CHIX:MEDXZ
66GF Score
Medmix AG CHIX:MEDXZ
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF249.6 Mil mean?
Medmix AG (CHIX:MEDXZ) has a Long-Term Debt of CHF249.6 Mil as of Jun. 2026.
Is Medmix AG's Long-Term Debt too high?
Medmix AG's current Long-Term Debt is CHF249.6 Mil. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Long-Term Debt compare to GEV and ETN?
Medmix AG's Long-Term Debt of CHF249.6 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for an Industrial Products company?
A good Long-Term Debt depends on the Industrial Products industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medmix AG's current Long-Term Debt is CHF249.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Long-Term Debt is CHF249.6 Mil. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Long-Term Debt is CHF249.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05. GuruFocus considers Medmix AG to be Fairly Valued.

Key valuation signals for CHIX:MEDXZ:

  • Long-Term Debt: CHF249.6 Mil
  • GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score

Get the complete analysis for CHIX:MEDXZ

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.54
Price
CHF9.05
GF Value